BCOR, a gene involved in epigenetic regulation, is frequently inactivated in hematologic malignancies such as acute myeloid leukemia and myelodysplastic syndromes, and its mutations are often associated with poor prognosis (17, 18). This evidence concerns the gene BCOR and acute myeloid leukemia.